Infinity Pharmaceuticals | INFI - صافي الدخل





صافي الدخل تغيير تاريخ
AbbVie USD 1.82B 1.63B 2025-12
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cipla INR 6.76B 6.75B 2025-12
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -6.98M 360K 2025-09
CSL USD 401M 96.5M 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 148.4M 15.76M 2025-09
Incyte USD 299.28M 124.89M 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
J&J USD 5.12B 36M 2025-12
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12